Converging mechanisms in ethanol neurotoxicity
; Pautassi, Ricardo Marcos 
Otros responsables
Fecha
2022
Editorial
Academic Press Inc Elsevier Science
Revista
Título del libro
Advances in Neurotoxicology
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
2468-7480
eISSN
ISBN
978-0-323-91585-4
Idioma
Inglés
Tipo del evento
Clasificación temática
Palabras clave
Resumen
Alcohol use disorder is a condition in which the individual keeps drinking alcohol despite repeated attempts to stop or control such behavior, which in turn generates negative social, occupational, and health consequences. Animal models have been developed to reproduce the deleterious effects of excessive ethanol intake, including ethanol-induced conditioned inflammation. There are several mechanisms underlying ethanol-induced toxicity. The excitotoxicity and downstream effects resultant of an imbalance in excitatory/inhibitory currents and the products of ethanol metabolism, in conjunction with the oxidative microenvironment product of oxidative/nitrosative stress rank among the most accepted mechanisms contributing to ethanol-induced neuronal dysfunction. Yet the emergence of mitochondrial dysfunction that decreases ATP along with increases in intracellular Ca2+ concentrations, plus the disruption of the NADH/NAD+ ratio is also relevant. Ferrous Fe overload and the inflammatory damage due to excessive alcohol intake or withdrawal are also key players underlying ethanol-induced neurotoxicity. Furthermore, a relationship between neuroinflammation and oxidative stress is recognized as a result of dopamine metabolism, inadequate functionality of the cystine-glutamate antiporter, mitochondrial dysfunction, and peripheral inflammation, that altogether lead to cell death. On this basis, a few therapeutic approaches have been approved to treat alcohol use disorder, albeit many others are still under scrutiny. The knowledge of the cellular and molecular mechanisms underlying alcohol use disorder is needed to provide new insights that fuel the development of new pharmacologically-relevant treatments.
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
